ATE232108T1 - Interleukin - 8 als antivirale- und antitumorwirkstoffe - Google Patents

Interleukin - 8 als antivirale- und antitumorwirkstoffe

Info

Publication number: ATE232108T1
Authority: AT; Austria
Prior art keywords: interleukin; antiviral; actives; antitumor; antitumor actives
Prior art date: 1996-07-05

Application number

AT97929060T

Other languages

English (en)

Inventor

Jean Gosselin

Pierre Borgeat

Bassam Damaj

Original Assignee

Virocell Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-05

Filing date

1997-07-04

Publication date

2003-02-15

1997-07-04 Application filed by Virocell Inc filed Critical Virocell Inc

2003-02-15 Application granted granted Critical

2003-02-15 Publication of ATE232108T1 publication Critical patent/ATE232108T1/de

Links

102000004890 Interleukin-8 Human genes 0.000 title abstract 3
108090001007 Interleukin-8 Proteins 0.000 title abstract 3
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 title abstract 3
229940096397 interleukin-8 Drugs 0.000 title abstract 3
230000000259 anti-tumor effect Effects 0.000 title 1
230000000840 anti-viral effect Effects 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2053—IL-8
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT97929060T 1996-07-05 1997-07-04 Interleukin - 8 als antivirale- und antitumorwirkstoffe ATE232108T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/674,633 US5900235A (en)	1996-07-05	1996-07-05	Interleukin-8 as an antiviral and antitumor agent
PCT/CA1997/000479 WO1998001150A1 (en)	1996-07-05	1997-07-04	Interleukin-8 as an antiviral and antitumor agent

Publications (1)

Publication Number	Publication Date
ATE232108T1 true ATE232108T1 (de)	2003-02-15

Family

ID=24707360

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97929060T ATE232108T1 (de)	1996-07-05	1997-07-04	Interleukin - 8 als antivirale- und antitumorwirkstoffe

Country Status (12)

Country	Link
US (1)	US5900235A (de)
EP (1)	EP0909178B1 (de)
JP (1)	JP2000514066A (de)
KR (1)	KR20000023562A (de)
AT (1)	ATE232108T1 (de)
AU (1)	AU713675B2 (de)
BR (1)	BR9710206A (de)
CA (1)	CA2258697A1 (de)
DE (1)	DE69718911T2 (de)
ES (1)	ES2191842T3 (de)
NZ (1)	NZ333605A (de)
WO (1)	WO1998001150A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7244349B2 (en)	1997-12-17	2007-07-17	Molecular Devices Corporation	Multiaperture sample positioning and analysis system
US20020144905A1 (en)	1997-12-17	2002-10-10	Christian Schmidt	Sample positioning and analysis system
US7270730B2 (en)	2000-08-04	2007-09-18	Essen Instruments, Inc.	High-throughput electrophysiological measurement system
US7067046B2 (en)	2000-08-04	2006-06-27	Essen Instruments, Inc.	System for rapid chemical activation in high-throughput electrophysiological measurements
US6962971B2 (en) *	2001-03-16	2005-11-08	The Regents Of The University Of California	Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
EP1562608A4 (de) *	2002-10-24	2010-09-01	Paratek Pharm Innc	Verfahren zur verwendung von substituiertentetracyclin-verbindungen zur modulierung der rna
US20070082068A1 (en) *	2003-11-25	2007-04-12	Hideo Satsu	Il-8 production promoters and use thereof
KR20230086610A (ko)	2021-12-07	2023-06-15	재단법인 아산사회복지재단	Il-12를 발현하는 재조합 백시니아 바이러스 및 이의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3681795A (en) *	1994-09-23	1996-04-09	University Of Nebraska Board Of Regents	Polypeptide agonists and antagonists of human interleukin-8

1996
- 1996-07-05 US US08/674,633 patent/US5900235A/en not_active Expired - Lifetime
1997
- 1997-07-04 CA CA002258697A patent/CA2258697A1/en not_active Abandoned
- 1997-07-04 DE DE69718911T patent/DE69718911T2/de not_active Expired - Fee Related
- 1997-07-04 AU AU33314/97A patent/AU713675B2/en not_active Ceased
- 1997-07-04 AT AT97929060T patent/ATE232108T1/de not_active IP Right Cessation
- 1997-07-04 ES ES97929060T patent/ES2191842T3/es not_active Expired - Lifetime
- 1997-07-04 BR BR9710206A patent/BR9710206A/pt not_active IP Right Cessation
- 1997-07-04 NZ NZ333605A patent/NZ333605A/xx unknown
- 1997-07-04 EP EP97929060A patent/EP0909178B1/de not_active Expired - Lifetime
- 1997-07-04 JP JP10504609A patent/JP2000514066A/ja active Pending
- 1997-07-04 WO PCT/CA1997/000479 patent/WO1998001150A1/en not_active Ceased
1999
- 1999-01-04 KR KR1019997000005A patent/KR20000023562A/ko not_active Ceased

Also Published As

Publication number	Publication date
EP0909178A1 (de)	1999-04-21
WO1998001150A1 (en)	1998-01-15
AU3331497A (en)	1998-02-02
DE69718911T2 (de)	2003-12-24
JP2000514066A (ja)	2000-10-24
US5900235A (en)	1999-05-04
CA2258697A1 (en)	1998-01-15
BR9710206A (pt)	1999-08-10
DE69718911D1 (de)	2003-03-13
EP0909178B1 (de)	2003-02-05
ES2191842T3 (es)	2003-09-16
KR20000023562A (ko)	2000-04-25
NZ333605A (en)	2000-12-22
AU713675B2 (en)	1999-12-09

Legal Events

Date

Code

Title

Description

2003-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0909178

Country of ref document: EP

2005-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DK1027359T3 (da)	2003-08-11	Monocykliske L-nukleosider, analoger og anvendelser deraf
BRPI0411900A (pt)	2006-09-19	compostos antivirais e métodos
ES2191292T3 (es)	2003-09-01	Compuestos antivirales poliaromaticos.
FI953717L (fi)	1995-08-04	4-Hydroksibentsopyran-2-oneja ja 4-hydroksisykloalkyyli(b)pyran-2-oneja, joita voidaan käyttää retrovirusinfektioiden hoitamiseen
EA199901031A1 (ru)	2000-06-26	Производные бензимидазола
FI20001231A7 (fi)	2000-05-23	2-Deoksi-2,3-didehydro-N-asetyylineuramiinihapon johdannaisia ja niiden analogeja ja niiden käyttö antiviraalisina aineina
EP0676954A4 (de)	1996-10-09	Hiv-lockvirus.
EA200000840A1 (ru)	2001-02-26	Антивирусные производные пиримидина
ATE219366T1 (de)	2002-07-15	Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b
KR950700298A (ko)	1995-01-16	뉴클레오시드 치료제(Therapeutic Nucleosides)
ATE346651T1 (de)	2006-12-15	Nucleoside mit anti-hepatitis b virus wirksamkeit
ATE185483T1 (de)	1999-10-15	Antivirale nucleosidkombination
DK0745852T3 (da)	2002-10-14	Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
DE3773892D1 (de)	1991-11-21	Medizinische verwendung von nukleosiden.
UA29466C2 (uk)	2000-11-15	Фармацевтична композиція з антипухлинною активністю
ES2123048T3 (es)	1999-01-01	Analogos de nucleosidos antiviricos.
ATE232108T1 (de)	2003-02-15	Interleukin - 8 als antivirale- und antitumorwirkstoffe
EA199900843A1 (ru)	2000-04-24	Синтез 1,3-оксаселеноланнуклеозидов, их активность против вируса иммунодефицита человека и против вируса гепатита-b
SE0004710L (sv)	2002-06-20	System och förfarande
DE68910577D1 (de)	1993-12-16	Mittel gegen den AIDS-Virus.
MX9203217A (es)	1992-07-01	Nucleosidos terapeuticos.
ATE147746T1 (de)	1997-02-15	Derivate von fluorphosphonat-nukleotiden
PT948967E (pt)	2005-02-28	Tratamento de doencas virais em suicos
MX9201288A (es)	1992-10-01	Metodo de tratamiento.
ATE112686T1 (de)	1994-10-15	Verwendungsmethoden von humanem gammainterferon 4-134.